Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: A pooled analysis from the international lung cancer consortium

Journal of the National Cancer Institute

Volumn 102, Issue 13, 2010, Pages 959-971

  Truong, Therese ^a,b   Hung, Rayjean J ^c   Amos, Christopher I ^d   Wu, Xifeng ^d   Bickeböller, Heike ^e   Rosenberger, Albert ^e   Sauter, Wiebke ^f   Illig, Thomas ^f   Wichmann, H Erich ^f   Risch, Angela ^g   Dienemann, Hendrik ⁱ   Kaaks, Rudolph ^j   Yang, Ping ⁱ   Jiang, Ruoxiang ⁱ   Wiencke, John K ^k   Wrensch, Margaret ^k   Hansen, Helen ^k   Kelsey, Karl T ^l   Matsuo, Keitaro ^m   Tajima, Kazuo ^m   Schwartz, Ann G ⁿ   Wenzlaff, Angie ⁿ   Seow, Adeline ^o   Ying, Chen ^o   Staratschek Jox, Andrea ^p   Nürnberg, Peter ^q   Stoelben, Erich ^r   Wolf, Jürgen ^s   Lazarus, Philip ^s   Muscat, Joshua E ^s   Gallagher, Carla J ^s   Zienolddiny, Shanbeh ^t   Haugen, Aage ^t   Van Der Heijden, Henricus F M ^u   Kiemeney, Lambertus A ^v   Isla, Dolores ^w   Mayordomo, Jose Ignacio ^x   Rafnar, Thorunn ^x   Stefansson, Kari ^x,y   Zhang, Zuo Feng ^z   Chang, Shen Chih ^z   Kim, Jin Hee ^aa,ab   Hong, Yun Chul ^s,aa,ab   Duell, Eric J ^ab,ac   Andrew, Angeline S ^ac   Lejbkowicz, Flavio ^ad   Rennert, Gad ^ad   Müller, Heiko ^h   Brenner, Hermann ^h   Le Marchand, Loïc ^ae   Benhamou, Simone ^af,ag   Bouchardy, Christine ^ah   Teare, M Dawn ^v   Xue, Xiaoyan ^ai   McLaughlin, John ^aj,ak   Liu, Geoffrey ^al   McKay, James D ^a   Brennan, Paul ^a   Spitz, Margaret R ^d   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TEXAS   (United States)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g Division of Epigenomics and Cancer Risk Factors   (Germany)

^h Division of Clinical Epidemiology and Aging Research   (Germany)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k MAYO CLINIC CANCER CENTER   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m BROWN UNIVERSITY   (United States)

ⁿ AICHI CANCER CENTER HOSPITAL   (Japan)

^o WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^q UNIVERSITY OF BONN   (Germany)

^r UNIVERSITY OF COLOGNE   (Germany)

^s UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^t PENN STATE COLLEGE OF MEDICINE   (United States)

^u NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^v Department of Internal Medicine Center for Integrated Oncology University Hospital Cologne ^*  (United States)

^w RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^x HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^y DECODE GENETICS   (Iceland)

^z UNIVERSITY OF ICELAND   (Iceland)

^aa UNIVERSITY OF CALIFORNIA   (United States)

^ab Seoul National University College of Medicine   (South Korea)

^ac CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^ad DARTMOUTH MEDICAL SCHOOL   (United States)

^ae CLALIT HEALTH SERVICES   (Israel)

^af UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^ag FONDATION JEAN DAUSSET CEPH   (France)

^ah INSTITUT GUSTAVE ROUSSY   (France)

^ai GENEVA CANCER REGISTRY   (Switzerland)

^aj UNIVERSITY OF SHEFFIELD   (United Kingdom)

^ak CANCER CARE ONTARIO   (Canada)

^al PRINCESS MARGARET HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 15Q; CHROMOSOME 5P; CHROMOSOME 6P; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENOME ANALYSIS; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SQUAMOUS CELL CARCINOMA; CANADA; CASE CONTROL STUDY; CAUCASIAN; CHROMOSOME 15; CHROMOSOME 5; CHROMOSOME 6; ETHNOLOGY; EUROPE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; HOMOZYGOTE; INTERNATIONAL COOPERATION; JAPAN; KOREA; LARGE CELL CARCINOMA; LUNG TUMOR; META ANALYSIS; MIDDLE AGED; QUALITY CONTROL; RISK; RISK ASSESSMENT; RISK FACTOR; SINGAPORE; SMALL CELL CARCINOMA; TOBACCO DEPENDENCE; UNITED STATES;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CANADA; CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 6; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HOMOZYGOTE; HUMANS; INTERNATIONAL COOPERATION; JAPAN; KOREA; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTORS; SINGAPORE; SMOKING; TOBACCO USE DISORDER; UNITED STATES;

EID: 77954715678     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq178     Document Type: Article

References (45)

1. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifes a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008;40(5):616-622.
2. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008;452(7187):633-637.
3. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452(7187):638-642.
4. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet. 2008;40(12):1404-1406.
5. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants infuence lung cancer risk. Nat Genet. 2008;40(12):1407-1409.
6. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet. 2009;41(2): 221-227.
7. Hung RJ, Christiani DC, Risch A, et al. International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev. 2008;17(11): 3081-3089.
8. Heck J, Andrew A, Onega T, et al. Lung cancer in a US population with low to moderate arsenic exposure. Environ Health Perspect. 2009;117(11): 1718-1723.
9. Gallagher CJ, Muscat JE, Hicks AN, et al. The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specifc association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation pheno-type and risk for lung cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16(4):823-828.
10. Cui Y, Morgenstern H, Greenland S, et al. Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer. 2006; 118(3):714-720.
11. Wrensch MR, Miike R, Sison JD, et al. CYP1A1 variants and smoking-related lung cancer in San Francisco Bay area Latinos and African Americans. Int J Cancer. 2005;113(1):141-147.
12. Zienolddiny S, Campa D, Lind H, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis. 2006;27(3): 560-567.
13. Sauter W, Rosenberger A, Beckmann L, et al. Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1127-1135.
14. Wichmann HE, Gieger C, Illig T. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen. 2005;67(suppl 1):S26-S30.
15. Wichmann HE, Rosario AS, Heid IM, Kreuzer M, Heinrich J, Kreienbrock L. Increased lung cancer risk due to residential radon in a pooled and extended analysis of studies in Germany. Health Phys. 2005;88(1):71-79.
16. Boeing H, Wahrendorf J, Becker N. EPIC-Germany-a source for studies into diet and risk of chronic diseases. European Investigation into Cancer and Nutrition. Ann Nutr Metab. 1999;43(4):195-204.
17. Breitling LP, Raum E, Muller H, Rothenbacher D, Brenner H. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology. 2009;49(3):802-808.
18. Kim JH, Kim H, Lee KY, et al. Genetic polymorphisms of ataxia telangi-ectasia mutated affect lung cancer risk. Hum Mol Genet. 2006;15(7): 1181-1186.
19. Suzuki T, Matsuo K, Hiraki A, et al. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study. Carcinogenesis. 2007;28(8):1718-1725.
20. Saccone SF, Hinrichs AL, Saccone NL, et al. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet. 2007;16(1): 36-49.
21. Berrettini W, Yuan X, Tozzi F, et al. Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry. 2008; 13(4):368-373.
22. Spitz MR, Amos CI, Dong Q, Lin J, Wu X. The CHRNA5-A3 region on chromosome 15q24-25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst. 2008;100(21):1552-1556.
23. Weiss RB, Baker TB, Cannon DS, et al. A candidate gene approach iden-tifes the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet. 2008;4(7):e1000125.
24. Caporaso N, Gu F, Chatterjee N, et al. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS ONE. 2009;4(2): e4653.
25. Le Marchand ML, Derby KS, Murphy SE, et al. Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobacco-specifc nitrosamine. Cancer Res. 2008;68(22):9137- 9140.
26. Bierut LJ, Madden PA, Breslau N, et al. Novel genes identifed in a high-density genome wide association study for nicotine. Hum Mol Genet. 2007;16(1):24-35.
27. Saccone NL, Saccone SF, Hinrichs AL, et al. Multiple distinct risk loci for nicotine dependence identifed by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(4):453-466.
28. Shiraishi K, Kohno T, Kunitoh H, et al. Contribution of nicotine acetylcho-line receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis. 2009;30(1):65-70.
29. Wu C, Hu Z, Yu D, et al. Genetic variants on chromosome 15q25 associated with lung cancer risk in Chinese populations. Cancer Res. 2009;69(12): 5065-5072.
30. Jin G, Xu L, Shu Y, et al. Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis. 2009;30(6):987-990.
31. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifes fve susceptibility loci for glioma. Nat Genet. 2009;41(8): 899-904.
32. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009;41(8):905-908.
33. Mushiroda T, Wattanapokayakit S, Takahashi A, et al. A genome-wide association study identifes an association of a common variant in TERT with susceptibility to idiopathic pulmonary fbrosis. J Med Genet. 2008; 45(10):654-656.
34. Janknecht R. On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett. 2004;564(1-2):9-13.
35. Lantuejoul S, Salon C, Soria JC, Brambilla E. Telomerase expression in lung preneoplasia and neoplasia. Int J Cancer. 2007;120(9):1835-1841.
36. Mavrogiannou E, Strati A, Stathopoulou A, Tsaroucha EG, Kaklamanis L, Lianidou ES. Real-time RT-PCR quantifcation of human telomerase reverse transcriptase splice variants in tumor cell lines and non-small cell lung cancer. Clin Chem. 2007;53(1):53-61.
37. Wu TC, Lin P, Hsu CP, et al. Loss of telomerase activity may be a potential favorable prognostic marker in lung carcinomas. Lung Cancer. 2003;41(2):163-169.
38. Han J, Qureshi AA, Prescott J, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2009;129(2): 415-421.
39. Risques RA, Vaughan TL, Li X, et al. Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2007;16(12):2649-2655.
40. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res. 2007;67(11):5538-5544.
41. Widmann TA, Herrmann M, Taha N, Konig J, Pfreundschuh M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lym-phomagenesis. Exp Hematol. 2007;35(6):939-946.
42. Wu X, Amos CI, Zhu Y, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst. 2003;95(16):1211-1218.
43. Zhu CQ, Cutz JC, Liu N, et al. Amplifcation of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br J Cancer. 2006;94(10):1452-1459.
44. Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, Okada H. HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev. 2007;21(7):848-861.
45. Her C, Zhao N, Wu X, Tompkins JD. MutS homologues hMSH4 and hMSH5: diverse functional implications in humans. Front Biosci. 2007;12:905-911.